Luffa Tablet, Orally Disintegrating
Product Images NDC 60986-2025

2 FDA label images from Marco Pharma International Llc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Luffa (NDC 60986-2025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marco Pharma International Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dd1d7740 C5d3 F0a6 E053 2995a90acb05

Dd1d7740 C5d3 F0a6 E053 2995a90acb05
Luffa orally disintegrating tablet, white and round with a score line across the middle, shown on a green textured background. This human OTC drug is manufactured by Marco Pharma International LLC. The image focuses on a single tablet without visible markings or imprints.*
FDA Label Image

N2_60986-2025-2 (N2 60986 2025 2)

N2_60986-2025-2 (N2 60986 2025 2)
This label panel for Luffa homeopathic combination medicine by Marco Pharma International LLC includes dosage instructions, warnings, tamper evidence information, and ingredients. It states it is for temporary relief of sinus symptoms and hay fever, contains 60 orally disintegrating tablets, and lists active ingredients with potencies. The label also notes the presence of milk and lactose.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.